Development of a cell-based diabetic wound assay

Area of Science:

• Biomedical Engineering
• Cell Biology
• Dermatology

Background:

• Chronic wounds significantly impact patient quality of life, especially in the growing diabetic population.
• Current animal models for chronic wound research are inadequate and cause animal suffering.
• Developing effective treatments for chronic diabetic wounds is hindered by research limitations.

Purpose of the Study:

• To develop a human-based in vitro model for chronic diabetic wounds.
• To establish a high-throughput screening system for potential wound healing agents.
• To reduce reliance on animal models and associated suffering.

Main Methods:

• Isolation of healthy and diseased skin fibroblasts from patient biopsies.
• Immortalization of fibroblasts to create a stable cell line.
• Microarray analysis to identify gene expression differences.
• Development of a fluorescent reporter system using disease-specific genes.

Main Results:

• Identified distinct gene expression patterns between healthy and diseased fibroblasts.
• Selected disease-specific reporter genes for the model.
• Demonstrated proof-of-concept for a real-time diabetic wound reporter system.

Conclusions:

• The developed in vitro model offers a promising human-based approach for studying diabetic wound healing.
• This system can facilitate high-throughput screening of therapeutic agents.
• The model has the potential to reduce animal testing in chronic wound research.